Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cariprazine Monotherapy Versus Treatment as Usual for Major Depressive Disorder
NCT05933538Phase 4Not yet recruiting
- Sponsor
- Sultan Qaboos University
- Start
- Aug 2024
- Primary completion
- Aug 2030
- Modality
- Orthosteric Ligands
01
Overview
A Phase 4 trial of cariprazine in major depressive disorder (MDD), sponsored by Sultan Qaboos University. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
cariprazine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT05933538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05933538.